Archive for 'Tag Archives: 'ULB''
Bioxodes to develop antithrombotic peptide derived from tick saliva following €2.6 million seed funding round
Bioxodes SA, (Marche-en-Famenne, Belgium) a company developing products derived from natural sources, has completed a €2.6 million ($3.5 million) seed funding round thanks to a consortium of business angels and Belgian investment funds. €1.6 million of [...]
Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners
As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]
Endo Tools Therapeutics, a spin-off from the ULB (Universite Libre of Brussels, Belgium) and developer of advanced endoscopic medical devices to treat obesity, digestive tract tumors and type II diabetes has announced the closure of a [...]
Dr. Martine Piccart, Director of Medicine at the Jules Bordet Institute in Brussels, and Professor of Oncology at the Université Libre de Bruxelles (ULB) is the first Belgian to have won the David Karnofsky Memorial Award1. [...]
The ULB is demonstrating great innovation with the newly inaugurated ULB Neuroscience Institute (UNI) by taking into account the dimensions of the brain’s complexity, from molecular neuroscience to cognitive neuroscience, via neurophysiology and neuroimaging and uniting [...]
Human Waves (ULB, UMons) awarded prize for innovation at the Haute Ecole Condorcet (HEPH) “Talents de la Création” competition.
Human Waves has been awarded the prize for innovation at the Haute Ecole Condorcet (HEPH) “Talents de la Création” competition. On May 3rd, students of the 2nd Marketing BA of the HEPH announced the four prize-winners of the “Talents [...]
Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials
Following the approval of the pivotal phase III osteonecrosis trial of PREOB® last November (posted Nov. 9, 2012), Bone Therapeutics has just completed a €7.7 million Series D fundraising round. Of the raised funds, €6.1 million were [...]
Cédric Blanpain receives Liliane Bettencourt Prize for his outstanding quality of international publications!
Adding to his achievements (see article posted July 13th, 2012) and his award for stem cell research, Cédric Blanpain, professor at the ULB, WELBIO IRIBHM investigator and Faculty of Medicine of the ULB, has been announced [...]